An Open-Label, Double-Treatment Group Study to Evaluate the Efficacy and Safety of Human Allogeneic Bone-Marrow- Derived Mesenchymal Stromal Cell Product StromaForte Compared With Hyaluronic Acid for the Treatment of Knee Osteoarthritis

Clinical trial NCT07542808 · RECRUITING

Trial details

NCT number

NCT07542808

Sponsor

Cellcolabs Clinical SPV Limited

Status

RECRUITING

Phase

Phase 2, Phase 3

Study type

INTERVENTIONAL

Start date

2026-04-27

Primary completion

2027-09-27

Enrollment

140

View on ClinicalTrials.gov